Delivery Order SPE2DB20D3101-SPE2DB24FRGN5
Award Date 4/15/24
Potential Completion Date 4/16/24
Potential Value $18K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA). The contract, valued at $1,951.13, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of April 26, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,192.67 for 4,559,700,837 units of NARCAN 4 MG NASAL SPRAY 2S. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), and has an ultimate completion date of January 25, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of NARCAN 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,193.76 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of May 31, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of NARCAN 4 MG NASAL SPRAY 2S. The contract, valued at $3,627.34, was awarded by the Defense Logistics Agency (DLA) and is a Firm Fixed Price Delivery Order. The contract has an ultimate completion date of May 6, 2024. This award is not designated with a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of NARCAN 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $6,652.14, has a completion date of February 7, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of NARCAN 4 MG NASAL SPRAY 2S. The $2,354.53 firm-fixed-price contract has an ultimate completion date of January 25, 2023. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,989.00 and a completion date of June 17, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of NARCAN 4 MG NASAL SPRAY 2S over a period ending on April 16, 2024. The contract, valued at $2,213.85, was awarded by the Defense Logistics Agency (DLA) under a Firm Fixed Price delivery order. Amerisourcebergen has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of NARCAN 4 MG NASAL SPRAY 2S for the Defense Logistics Agency (DLA). The contract has a ceiling value of $8,285.98 and an ultimate completion date of May 23, 2024. It is a firm fixed-price delivery order contract with no set-aside requirements. Amerisourcebergen Drug Corp is the prime contractor, and this award is part of a larger Indefinite Delivery Contract (IDC) valued at...
- This federal contract award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdose, to the Defense Logistics Agency (DLA). The $7,940.14 delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 10, 2023, with a completion date of May 11, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract (IDC) valued at up to...